Yelin Lapidot Holdings Management Ltd. Arvinas, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $548 Billion
- Q2 2025
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 46,665 shares of ARVN stock, worth $453,583. This represents 0.06% of its overall portfolio holdings.
Number of Shares
46,665
Previous 46,665
-0.0%
Holding current value
$453,583
Previous $328 Million
4.84%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.2MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$91.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$60.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$35.7 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$32.1 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$20.9 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $517M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...